首页> 美国卫生研究院文献>EBioMedicine >Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimers Disease and Mild Cognitive Impairment: A Multicenter Randomized Double-blind Placebo-controlled Trial
【2h】

Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimers Disease and Mild Cognitive Impairment: A Multicenter Randomized Double-blind Placebo-controlled Trial

机译:轻度阿尔茨海默氏病和轻度认知障碍患者口服血浆生成素的疗效和血中血浆生成素变化:多中心随机双盲安慰剂对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPlasmalogens (Pls) reportedly decreased in postmortem brain and in the blood of patients with Alzheimer's disease (AD). Recently we showed that intraperitoneal administration of Pls improved cognitive function in experimental animals. In the present trial, we tested the efficacy of oral administration of scallop-derived purified Pls with respect to cognitive function and blood Pls changes in patients with mild AD and mild cognitive impairment (MCI).
机译:背景据报道,阿尔茨海默氏病(AD)患者的死后大脑和血液中的血浆致黄素(Pls)减少。最近,我们显示腹膜内注射Pls可改善实验动物的认知功能。在本试验中,我们测试了轻度AD和轻度认知障碍(MCI)患者口服给药扇贝衍生的纯化Pls对认知功能和血液Pls变化的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号